MedCity News December 13, 2021
Integrated software, accessible genetic data, and advances in precision medicine can transform the lives of millions of patients–if the clinical trial and larger medical industry embrace these trends.
Precision medicine—treatment personalized for a patient based on their genetic or molecular profile—has steadily grown in popularity in the medical community. Physicians have seen success using precision medicine for serious illnesses like depression, colon cancer, and leukemia after testing those treatments during clinical trials.
But precision medicine is still far from universally understood by patients. A 2020 survey showed that two-thirds of Americans had never heard of precision medicine, and only 11% had discussed precision medicine treatments with their doctors.
If precision treatments often work, why have so few eligible people received...